Imperva (IMPV) Lowered to “Underweight” at J P Morgan Chase & Co

J P Morgan Chase & Co lowered shares of Imperva (NASDAQ:IMPV) from a neutral rating to an underweight rating in a research note released on Tuesday morning, Marketbeat.com reports. The firm currently has $45.00 target price on the software maker’s stock.

Several other equities research analysts have also recently issued reports on IMPV. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 target price on shares of Imperva and gave the stock a buy rating in a report on Monday, August 28th. Zacks Investment Research cut shares of Imperva from a strong-buy rating to a hold rating in a report on Wednesday, September 27th. Wells Fargo & Company cut shares of Imperva from an outperform rating to a market perform rating in a report on Monday, October 9th. Finally, William Blair cut shares of Imperva from an outperform rating to a market perform rating in a report on Tuesday, October 10th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Imperva presently has a consensus rating of Hold and an average price target of $51.86.

Shares of Imperva (NASDAQ IMPV) opened at $41.05 on Tuesday. Imperva has a fifty-two week low of $37.05 and a fifty-two week high of $52.40.

Imperva (NASDAQ:IMPV) last issued its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $83.89 million for the quarter, compared to analysts’ expectations of $83.79 million. During the same quarter last year, the company posted $0.08 earnings per share. The firm’s quarterly revenue was up 22.6% on a year-over-year basis. equities analysts forecast that Imperva will post -0.52 earnings per share for the current year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Imperva by 4.3% in the second quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after acquiring an additional 99,799 shares during the period. BlackRock Inc. raised its position in shares of Imperva by 11.3% during the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after purchasing an additional 215,170 shares during the period. Eagle Asset Management Inc. raised its position in shares of Imperva by 1.2% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,294,651 shares of the software maker’s stock valued at $55,928,000 after purchasing an additional 14,803 shares during the period. Alyeska Investment Group L.P. raised its position in shares of Imperva by 89.3% during the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after purchasing an additional 428,163 shares during the period. Finally, ETF Managers Group LLC bought a new stake in shares of Imperva during the 2nd quarter valued at $41,888,000. Institutional investors and hedge funds own 96.95% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Imperva (IMPV) Lowered to “Underweight” at J P Morgan Chase & Co” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally copied and republished in violation of international copyright and trademark laws. The legal version of this story can be viewed at https://www.com-unik.info/2017/12/16/imperva-impv-lowered-to-underweight-at-j-p-morgan-chase-co.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

What are top analysts saying about Imperva? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit